| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 90,459 | 76,564 | 75,591 | 106,965 | | Cost of Revenue | 55,865 | 49,874 | 47,676 | 65,002 | | | Gross Profit | 34,594 | 26,690 | 27,915 | 41,963 | | | Operating Expenses | | Research Development | 6,749 | 8,764 | 7,525 | 8,462 | | Selling General and Administrative | 21,646 | 23,168 | 19,536 | 23,037 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 887 | 972 | 876 | 824 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,312 | (6,214) | (22) | 9,640 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,805 | 883 | 1,922 | 2,125 | | Earnings Before Interest And Taxes | 7,777 | (5,331) | 1,900 | 11,765 | | Interest Expense | 394 | 315 | 380 | 662 | | Income Before Tax | 7,383 | (5,646) | 1,520 | 11,103 | | Income Tax Expense | 2,357 | (798) | 285 | 3,353 | | Minority Interest | (115) | (52) | (69) | (104) | | | | Net Income From Continuing Ops | 4,911 | (4,900) | 1,166 | 7,646 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,251 | (4,900) | 1,166 | 7,646 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,251 | ($4,900) | $1,166 | $7,646 |
|
0.13% Nasdaq 
Income Statement
